Expanding the universe of druggable targets

Non-viral delivery platform enables efficient delivery of emerging treatment modalities

Novel technology, new treatment opportunities

Unlocking the full potential of genetic medicines
High-capacity loading of gene editors, RNA and protein-based therapeutics
Efficient biodistribution to a broad range of cell and tissue types
Low complexity scalable manufacturing

Engineering naturally occurring vesicles to deliver therapeutic payloads

ARRDC1-Mediated Microvesicles (ARMMs) are a natural communication system used to relay intercellular signals. Vesigen has developed proprietary methods to equip ARMMs with therapeutic payloads and overcome fundamental challenges associated with conventional delivery approaches.

Explore our science

Join a team that’s creating transformative therapeutics

Powered by our breakthrough in engineering ARMMs technology, Vesigen will deliver tomorrow’s precision medicines. If you’re looking for a career opportunity with truly innovative science and potential to transform patient lives, you’re in the right place.

See current opportunities